“The chip enables us to grow our own human cells and observe a drug’s effect on them in their natural environment,”
On a rectangular chip slightly smaller than a person’s finger, two scientists and an engineer are writing what they hope will be the blueprint for the future of drug testing.
The researchers are studying the behaviors of cells to learn more about how cells send signals to each other. How are cells affected by the flow of blood? And how can they be studied outside the body?
The problem that the group hopes to solve is a challenge that confronts many cancer patients: How can drugs be made to kill cancerous cells without harming healthy cells and tissue nearby?
The researchers represent three disciplines. Yaling Liu, assistant professor of mechanical engineering and mechanics, studies the interfacial phenomena that occur at the micro- and nanoscale of biological systems.
Linda Lowe-Krentz, professor of biological sciences, is a cell biologist who studies blood vessels and the changes that cells undergo in response to blood flow.
And Daniel Ou-Yang, professor of physics, has developed novel methods of using microscopy and lasers, including “optical tweezers,” to study the activities of cells at the nanoscale.
The researchers and their students are developing a method of testing cancer drugs on a chip etched with channels that mimic the branching capillaries of the human lung and are coated with human endothelial, or blood vessel, cells.
In addition to learning how to target drugs selectively at cancerous cells, they hope to reduce the cost of drug tests as well as the time it takes to run them.
The project has been supported for more than a year through Lehigh’s Biosystems Dynamics Summer Institute, which is funded by the Howard Hughes Medical Institute. The group recently received a three-year grant from the National Institutes of Health.
An alternative to invasive therapies
Current cancer treatments, says Liu, can be extremely invasive. Most chemotherapies, for example, disperse an anti-cancer drug into the bloodstream, where it destroys both cancerous and noncancerous tissue and cells.
Standard drug-testing methods also have shortcomings, says Lowe-Krentz. Some tests are done in the static environment of cells and cultures, which don’t mimic the behavior of the entire organism. Others are performed on animals: this is expensive and the results can be unreliable because a drug’s effect on an animal is different from its effect on a human.
By conducting tests on a chip, says Liu, researchers can approximate the environment a drug encounters inside the human body and track its fate in that environment. Chips are cheap—each costs less than a dollar to make, and multiple tests can be run simultaneously on a series of chips. Size is another advantage. In a test, the small chip uses only about a tenth of the amount of drug and tissue required by more conventional testing methods.
“The chip enables us to grow our own human cells and observe a drug’s effect on them in their natural environment,” says Liu. “This will make it possible to do screenings much more quickly and shorten the research cycle.”
The Latest on: Lab-on-a-chip drug testing
- New treatments for liver disease could be identified with lab-on-a-chipon August 30, 2019 at 7:06 am
The lab-on-a-chip platform can also be used to assess investigational drugs’ effects on NAFLD progression, revealing their potential for further testing in clinical trials ... establishes a basis for ...
- 'Lab on a chip' technology may help find new treatments for NAFLDon August 29, 2019 at 2:27 pm
In addition, the lab on a chip platform can be used to assess investigational drugs' effects on NAFLD progression, therefore revealing their potential for further testing in clinical ... a basis for ...
- Lab-on-a-chip may help identify new treatments for liver diseaseon August 29, 2019 at 9:49 am
In addition, the lab on a chip platform can be used to assess investigational drugs' effects on NAFLD progression, therefore revealing their potential for further testing in clinical trials.
- Lab-on-a-chip drives search for new drugs to prevent blood clotson August 20, 2019 at 7:33 am
A new biocompatible lab-on-a-chip could help accelerate the discovery and development ... featuring a unique system of micropumps and analysis tools for testing the effect of chemical compounds on how ...
- Multi-Organ Lab-on-a-Chip for Cancer Drug Testingon June 20, 2019 at 8:15 am
Researchers at Hesperos, Inc., a biotech firm based in Florida, have collaborated with Roche and the University of Central Florida to develop a multi-organ lab-on-a-chip system for drug testing. The ...
- Biochip quickly tests results of cancer therapyon February 27, 2019 at 4:00 pm
We are providing more precise drug test conditions to insure that the results we are ... The researchers reported the details of their findings in the journal Lab on a Chip. The NSF Engineering ...
- FDA Approves Gene-Testing Device for Doctor's-Office Prescription Screeningon December 1, 2018 at 4:00 pm
It's not quite a lab-on-a-chip in terms of size ... but Nanosphere hopes to expand is rapid desktop testing to drugs for other conditions. For instance, the anticoagulant drug warfarin can help ...
- Lab-on-a-Chip Screens Compounds to Accelerate Drug Developmenton October 29, 2018 at 5:00 pm
Testing the characteristics of thousands of candidate compounds, with the majority “failing early,” lets only the most promising ones be further developed into drugs and perhaps eventually to undergo ...
- Raman Spectroscopy Helps Find the Right Drug with Drug Resistance Teston March 14, 2018 at 1:43 pm
Drug resistance among bacteria can be identified with Raman ... "We combine light-based analytical methods with microfluidic sample processing. With our Lab-on-a-Chip system, thus a miniaturized lab, ...
- NIST scientists discover how to switch liver cancer cell growth from 2-D to 3-D structureson November 16, 2017 at 9:56 am
To fulfill the promise of lab-on-a-chip technology, the chip's interior needs to ... cell cultures to be scaled up for the sort of high-throughput work a drug company would need to test large numbers ...
via Google News and Bing News